World Health Organization Issues Alert Over Critical Shortage of Weight-Loss Injections
Less than a tenth of patients who could benefit from weight-loss injections including Wegovy are able to get them, warns the global health agency as it issues its initial recommendations on the medications.
Considering more than one billion individuals worldwide currently obese, it is advocating for increased and just availability to GLP-1 medication.
According to projections, in excess of 2,000,000,000 could be obese by 2030 without intervention.
"Our new guidelines acknowledges that excess weight is a chronic disease that can be treated with holistic and ongoing support," remarked its chief Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and distribution challenges are key barriers to universal availability to the injections that can help people shift considerable weight, says the organization.
Skinny Jab Shortage
Despite the present best projected scenario, the production of these medications would only suffice for around 100 million people – under 10% of those who need them, per the WHO.
The advice calls on countries and companies to widen access, by measures such as patent sharing.
The intellectual property rights on the active ingredient – the main ingredient of the drug Wegovy – is scheduled to end in several nations in 2026.
How Weight-Loss Drugs Function
These medications mimick a body's own hormone to slow digestion, curb appetite and increase satiety so users eat less.
Individuals typically start to lose weight after several weeks of beginning the once-weekly jabs.
Research points to users may put most of the weight back on after a year of discontinuing the drug, because their typical food cravings return.
To be above a healthy weight elevates your risk for developing diseases, such as diabetes, cardiovascular issues, brain attack, and specific malignancies.
Excess weight concerns people in every country and was associated with over three and a half million deaths worldwide in 2024, as per the health agency.
